The introduction of the the medication vial marks a significant shift in the landscape to metabolic regulation. This novel medication combines dual mechanisms – activation of the GLP-1 site and reduction of the DPP-4 enzyme – providing a unique technique for addressing obesity . Early clinical results suggest substantial effectiveness in assist